CA Stock MarketDetailed Quotes
DTC Defence Therapeutics Inc
- 0.650
- 0.0000.00%
15min DelayMarket Closed Jan 3 15:36 ET
30.97MMarket Cap-2.50P/E (TTM)
0.650High0.620Low18.50KVolume0.650Open0.650Pre Close12.01KTurnover2.42052wk High0.04%Turnover Ratio47.65MShares0.48052wk Low-0.26EPS TTM29.56MFloat Cap8.150Historical HighLossP/E (Static)45.48MShs Float0.480Historical Low-0.3EPS LYR4.62%Amplitude--Dividend TTM-7.47P/B1Lot Size--Div YieldTTM
Defence Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -75.94%508.67K | 95.89%12.82M | -31.16%1.19M | -2.56%1.21M | 334.29%8.31M | 27.13%2.11M | -10.58%6.55M | -20.49%1.73M | -25.95%1.24M | -1.44%1.91M |
| Selling and administrative expenses | -77.99%213.57K | 211.66%8.44M | -57.64%433.04K | -53.01%439.14K | 1,023.04%6.59M | 494.45%970.4K | -23.95%2.71M | 6.75%1.02M | 45.66%934.45K | -45.06%587.23K |
| -Selling and marketing expense | ---- | ---- | ---- | -73.34%205.19K | 101.62%514.25K | ---- | ---- | ---- | 50.21%769.52K | -61.05%255.06K |
| -General and administrative expense | -77.99%213.57K | 211.66%8.44M | -6.73%2.01M | 41.84%233.95K | 1,730.56%6.08M | 1,540.49%970.4K | 161.39%2.71M | 355.02%2.15M | 27.63%164.93K | -19.79%332.17K |
| Research and development costs | -88.03%126.34K | 7.82%3.86M | -4.63%596.7K | 148.67%641.86K | 25.93%1.57M | -27.36%1.06M | -4.76%3.58M | -54.31%625.69K | -73.88%258.12K | 42.72%1.24M |
| Depreciation amortization depletion | 38.50%17.71K | 557.77%90.92K | 6,064.39%48.64K | 7,813.33%22.55K | -45.50%6.95K | --12.79K | --13.82K | --789 | --285 | --12.75K |
| -Depreciation and amortization | 38.50%17.71K | 557.77%90.92K | 6,064.39%48.64K | 7,813.33%22.55K | -45.50%6.95K | --12.79K | --13.82K | --789 | --285 | --12.75K |
| Other operating expenses | 98.54%151.05K | 77.91%432.15K | 41.40%110.39K | 116.99%106.64K | 103.37%139.05K | 60.79%76.08K | --242.9K | --78.07K | 3.73%49.15K | --68.37K |
| Operating profit | 75.94%-508.67K | -95.89%-12.82M | 31.16%-1.19M | 2.56%-1.21M | -334.29%-8.31M | -27.13%-2.11M | 10.58%-6.55M | 20.49%-1.73M | 25.95%-1.24M | 1.44%-1.91M |
| Net non-operating interest income (expenses) | -33.44%-107.97K | -46.79%-375.97K | -43.61%-148.61K | 8.34%-93.13K | -4.47%-53.32K | -80.91K | -256.12K | -103.48K | -101.6K | -51.04K |
| Non-operating interest income | -99.59%62 | 221.43%21.89K | 4,985.71%356 | -74.67%1.72K | --4.76K | --15.05K | --6.81K | --7 | --6.8K | --0 |
| Non-operating interest expense | 12.58%108.03K | 51.31%397.85K | 43.94%148.96K | -12.50%94.86K | 13.79%58.08K | --95.96K | --262.93K | --103.49K | --108.41K | --51.04K |
| Other net income (expenses) | 694.35%9.78K | 107.24%4.8K | -219.31%-10.87K | -5,447.05%-24.44K | 274.76%41.75K | 95.83%-1.65K | -377.79%-66.3K | -108.24%-3.4K | 102.62%457 | -23.89K |
| Gain on sale of security | 694.35%9.78K | 107.24%4.8K | -219.31%-10.87K | -5,447.05%-24.44K | 274.76%41.75K | 95.83%-1.65K | -377.79%-66.3K | -108.24%-3.4K | 102.62%457 | ---23.89K |
| Income before tax | 72.38%-606.86K | -92.10%-13.19M | 26.48%-1.35M | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 5.87%-6.87M | 13.93%-1.83M | 20.74%-1.34M | -2.42%-1.99M |
| Income tax | 0 | -105K | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 72.38%-606.86K | -95.08%-13.19M | 22.01%-1.35M | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 7.31%-6.76M | 18.86%-1.73M | 20.74%-1.34M | -2.42%-1.99M |
| Net income continuous operations | 72.38%-606.86K | -95.08%-13.19M | 22.01%-1.35M | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 7.31%-6.76M | 18.86%-1.73M | 20.74%-1.34M | -2.42%-1.99M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 72.38%-606.86K | -95.08%-13.19M | 22.01%-1.35M | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 7.91%-6.76M | 20.64%-1.73M | 20.74%-1.34M | -2.42%-1.99M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 72.38%-606.86K | -95.08%-13.19M | 22.01%-1.35M | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 7.91%-6.76M | 20.64%-1.73M | 20.74%-1.34M | -2.42%-1.99M |
| Diluted earnings per share | 80.00%-0.01 | -76.47%-0.3 | 25.00%-0.03 | 0.00%-0.03 | -280.00%-0.19 | 0.00%-0.05 | 15.00%-0.17 | 33.33%-0.04 | 40.00%-0.03 | 0.00%-0.05 |
| Basic earnings per share | 80.00%-0.01 | -76.47%-0.3 | 25.00%-0.03 | 0.00%-0.03 | -280.00%-0.19 | 0.00%-0.05 | 15.00%-0.17 | 33.33%-0.04 | 40.00%-0.03 | 0.00%-0.05 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data